Dr. Yoshiki Shimamura
Dr. Yoshiki Shimamura is Sage Group’s lead partner in Japan, and is fluent in Japanese, English and Korean. He has a PhD, Life Science Technology, Tokushima University, Japan; MSc, Pharmaceutical Science, Chiba University, Japan and BSc (Hons) Molecular Cell Biology, Saitama University, Japan. Yoshiki has over 20+ years pharmaceuticals experience in Japan, Korea, US and Europe; across management, clinical trial management, regulatory affairs, businesss development, and product marketing. He has strong expertise in a number of key theapeutic areas. He has played lead roles in Japanese and Korean pharma industries as Unit Head for the Oncology Business Unit and Director of Medical Affairs for Hospira Japan; Project Manager for Parexel in Japan; Board Director and Head of BD for Chong Kun Dang Pharmaceutical in Seoul; Director of Clinical Development for Symbio Pharmaceutical in Tokyo; Associate Director for Global Marketing at Amgen in Tokyo; Director at Pharmacia Japan and Project Manager for Taiho Pharmaceutical in Tokyo.